Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term 0 (Antineoplastic Combined Chemotherapy Protocols). Found 9 abstracts

Lauritsen JP, Haks MC, Lefebvre JM, Kappes DJ, Wiest DL, Chen X, Arciero CA, Godwin AK, Barsevick AM, Whitmer K, Nail LM, Beck SL, Dudley WN, Weiner LM, Treat J. Role of the transcription factor Th-POK in CD4:CD8 lineage commitment. . Immunological reviews. 2006 Feb;209(2):237-52.
Engstrom PF, Benson AB, Chen YJ, Choti MA, Dilawari RA, Enke CA, Fakih MG, Fuchs C, Kiel K, Knol JA, Leong LA, Ludwig KA, Martin EW, Rao S, Saif MW, Saltz L, Skibber JM, Venook AP, Yeatman TJ, National Comprehensive Cancer N. Rectal cancer clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network. 2005 Jul;3(4):492-508.
Engstrom PF, Benson AB, Chen YJ, Choti MA, Dilawari RA, Enke CA, Fakih MG, Fuchs C, Kiel K, Knol JA, Leong LA, Ludwig KA, Martin EW, Rao S, Saif MW, Saltz L, Skibber JM, Venook AP, Yeatman TJ, National Comprehensive Cancer N. Colon cancer clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network. 2005 Jul;3(4):468-91.
Langer CJ. Role of zoledronic acid in the setting of bone metastases from non-small-cell lung cancer. Clinical lung cancer. 2005 Jan;6(5):314-6, 2005 Mar.
Rogers B. Looking at lymphoma and leukemia. Nursing. 2005 Jul;35(7):56-63; quiz 63-4.
Gallo JM, Vicini P, Orlansky A, Li S, Zhou F, Ma J, Pulfer S, Bookman MA, Guo P. Pharmacokinetic model-predicted anticancer drug concentrations in human tumors. Clinical Cancer Research. 2004 Dec;10(23):8048-58.
Langer CJ. Irinotecan in advanced lung cancer: focus on North American trials. Oncology (Huntington). 2004 Jun;18(7 Suppl 4):17-28.
Langer C, Damsker J, Ridge A. Reirradiation: exploring new territory in the therapy of recurrent head and neck cancer. Clinical Advances in Hematology & Oncology. 2003 Jul;1(7):424-9, 440.
Sasson AR, Wetherington RW, Hoffman JP, Ross EA, Cooper H, Meropol NJ, Freedman G, Pingpank JF, Eisenberg BL. Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: analysis of histopathology and outcome. International Journal of Gastrointestinal Cancer. 2003 Jan;34(2-3):121-8.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term 0 (Antineoplastic Combined Chemotherapy Protocols)

0 (Antineoplastic Combined Chemotherapy Protocols) Antineoplastic Combined Chemotherapy Protocols dt [Drug Therapy] tu [Therapeutic Lung Neoplasms Use] aa [Analogs & Derivatives] rt [Radiotherapy] pa [Pathology] tu [Therapeutic Use] ad [Administration & Dosage] sc [Secondary] 951-77-9 (Deoxycytidine) su [Surgery] 103882-84-4 (gemcitabine) Neoplasm Staging Female di [Diagnosis] Middle Aged Fluorouracil th [Therapy] Camptothecin 51-21-8 (Fluorouracil) 15663-27-1 (Cisplatin) Lymphatic Metastasis tu Adjuvant Radiotherapy [Therapeutic Use] Liver Neoplasms Deoxycytidine 7689-03-4 (Camptothecin) Male st [Standards] Medical Oncology et [Etiology] Survival Analysis Brain Neoplasms Squamous Cell Carcinoma Secondary Hypertrophic Osteoarthropathy 0 (Diphosphonates) Imidazoles Computer Simulation 41575-94-4 (Carboplatin) Social Support Diphosphonates nu [Nursing] therapeutic Combined Modality Therapy Rectal Neoplasms Leukemia methods Colonic Neoplasms Adenocarcinoma Head and Neck Neoplasms EC 1-17-4 (Ribonucleotide Reductases) Radiotherapy Organoplatinum Compounds Colectomy Comparative Study Monoclonal Antibodies co [Complications] Neoadjuvant Therapy therapeutic use MH - Antineoplastic Combined Chemotherapy Protocols me [Metabolism] 0 (Sesquiterpenes) Retrospective Studies Antineoplastic Antimetabolites Human Heterologous Transplantation Phytogenic Antineoplastic Agents Predictive Value of Tests Patient Education North America Antineoplastic Agents Genetic Engineering Colonic Polyps Ribonucleotide Reductases Ovarian Neoplasms Phytogenic) 0 (Antineoplastic Agents immunology mt [Methods] Bone Neoplasms Monoclonal) 0 (Antibodies 0 (Radiation-Sensitizing Agents) Lymphoma 129298-91-5 (O-(chloroacetylcarbamoyl)fumagillol) therapeutic use MH - Clinical Tr Carboplatin Topotecan 0 (Organoplatinum Compounds) 58-05-9 (Leucovorin) 85622-93-1 (temozolomide) Adjuvant Chemotherapy Non-US Gov't Support Small Cell Carcinoma 0 (Taxoids) 0 (Folfox protocol) Colostomy pk Adult Vascular Endothelial Growth Factor A 123948-87-8 (Topotecan) 33419-42-0 (Etoposide) 0 (Vascular Endothelial Growth Factor A) Rats Disease Progression Cisplatin 80 and over Aged Non-Small-Cell Lung therapeutic use MH - Carcinoma 4342-03-4 (Dacarbazine) Leucovorin Non-US Gov't Research Support Inbred F344 Rats Local Neoplasm Recurrence Clinical Trials [Pharmacokinetics] Non-Small-Cell Lung Carcinoma Nude Rats Pancreatectomy Antineoplastic) 0 (Antimetabolites use Neoplasm Invasiveness Mitomycin Aged 0 (Antineoplastic Agents) 0 (bevacizumab) Etoposide drug therapy Type I DNA Topoisomerases NIH Research Support-Extramural Survival Rate human) 0 (vascular endothelial growth factor A 100286-90-6 (irinotecan) Vindesine Radiation-Sensitizing Agents 0 (Enzyme Inhibitors) administration & dosage 0 (IFL protocol) Lymph Node Excision Mice Risk Assessment Type I) EC 5-99-1-2 (DNA Topoisomerases 0 (Imidazoles) Salvage Therapy Dacarbazine Enzyme Inhibitors 118072-93-8 (zoledronic acid) Pancreatic Neoplasms ai [Antagonists & Inhibitors] Taxoids
Last updated on Wednesday, February 05, 2020